Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
How These Drugs Work: The Basics Both medicines help control blood sugar and can cause meaningful weight loss, but they work slightly differently
Et ultrices nunc donec placerat
Personal plans count
2 Department of Endocrinology, SANKO University Faculty of Medicine, Gaziantep, Turkey Correspondence: Nimet Ylmaz, Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey, Email [email protected] Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual GLP-1/GIP receptor agonists are highly effective agents for the treatment of type 2 diabetes and obesity
Table of Contents Understanding GLP-1 therapy in virtual care Key monitoring parameters for remote initiation Patient education and adherence strategies Addressing risks and optimizing outcomes Understanding GLP-1 Therapy in Virtual Care GLP-1 receptor agonists have transformed the management of type 2 diabetes and obesity
